Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application, Therapeutic Area, By Deployment Model, By Pricing Model, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application, Therapeutic Area, By Deployment Model, By Pricing Model, By End Use, By Region, And Segment Forecasts, 2025 - 2030


Medical Device Complaint Management Market Growth & Trends

The global medical device complaint management market size is estimated to reach USD 13.33 billion by 2030, registering a CAGR of 8.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing utilization of software aiding in the overall complaint management process is expected to increase the market growth. The growing adoption of the digital system over paper-based work for tracking medical complaints is further boosting the market growth.

The medical device industry is highly regulated and inadequate product complaint handling accounts for a large percentage of FDA inspection findings. The complaints create severe reputational and brand risks and they need to be officially documented, inspected, tracked, and closed. Complaints may be minor, but they may also include a potential risk to the safety of the patient or product function or quality, which could cause damage to the company. Thus, it is important that all the complaints are correctly recorded in automated and integrated complaint management solutions to ensure that they are accurately investigated and addressed.

An increase in the demand for medical complaint management solutions has been registered over the past few years owing to the streamlined process. Incidents are recorded and the data automatically drives the investigation and resolution workflow. Companies are attaining complete medical documentation with minimal errors along with reduced turnaround time on the account of fact that complaint management solutions offer advanced analytics and reporting tools for augmented management oversight.

Moreover, the majority of companies are coming up with mobile app solutions to manage customer medical complaints. For instance, Intellect and Beckman Coulter in collaboration with Impiger technologies provide a mobile app platform on Google Play Store and the App Store to their customers, which enables them to register complaints, escalate tickets, and generate an inquiry. In addition, regulators are gradually focusing on handling customer complaints, the safety of the product, and device vigilance in both developed and emerging economies.

Medical Device Complaint Management Market Report Highlights
  • The market is expected to grow owing to an increase in the adoption of automated complaint filing systems over a paper-based system.
  • By service type, the product surveillance and regulatory compliance segment emerged as the largest segment in 2024, owing to the fact that regulatory agencies and medical device users are increasingly focusing on product surveillance in order to avoid failure of the medical devices.
  • North America dominated the market in 2024, owing to the presence of regulatory requirements in the region, coupled with the high incidence of medical device complaints witnessed over the past few years.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. Therapeutic Area Segment
1.2.4. Deployment Model Segment
1.2.5. Pricing Model Segment
1.2.6. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Biosimulation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Growing demand for personalized medicine
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with biosimulation technology and software
3.2.2.2. Stringent regulatory requirements
3.3. Biosimulation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
3.4. COVID-19 Impact Analysis
Chapter 4. Biosimulation Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Biosimulation Market Product Movement Analysis
4.3. Global Biosimulation Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
4.4. Software
4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Molecular Modeling & Simulation Software
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Clinical Trial Design Software
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. PK/PD Modeling and Simulation Software
4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.5. Pbpk Modeling and Simulation Software
4.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.6. Toxicity Prediction Software
4.4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.7. Other Software
4.4.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Contract Services
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Consulting
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.4. Other (Implementation, Training, & Support, etc.)
4.5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. Biosimulation Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Biosimulation Market Application Movement Analysis
5.3. Global Biosimulation Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
5.4. Drug Discovery & Development
5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Disease Modeling
5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Other (Precision Medicine, Toxicology, etc.)
5.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Biosimulation Market: Therapeutic Area Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Biosimulation Market Therapeutic Area Movement Analysis
6.3. Global Biosimulation Market Size & Trend Analysis, by Therapeutic Area, 2018 - 2030 (USD Million)
6.4. Oncology
6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Cardiovascular Disease
6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Infectious Disease
6.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Neurological Disorders
6.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Biosimulation Market: Deployment Model Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Biosimulation Market Deployment Model Movement Analysis
7.3. Global Biosimulation Market Size & Trend Analysis, by Deployment Model, 2018 - 2030 (USD Million)
7.4. Cloud-based
7.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.5. On-premises
7.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Hybrid Model
7.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Biosimulation Market: Pricing Model Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Biosimulation Market Pricing Model Movement Analysis
8.3. Global Biosimulation Market Size & Trend Analysis, by Pricing Model, 2018 - 2030 (USD Million)
8.4. License-based Model
8.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
8.5. Subscription-based Model
8.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
8.6. Service-based Model
8.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
8.7. Pay Per Use Model
8.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 9. Biosimulation Market: End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Biosimulation Market End Use Movement Analysis
9.3. Global Biosimulation Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
9.4. Life Science Companies
9.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.4.2. Pharmaceutical Companies
9.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.4.3. Biopharma Companies
9.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.4.4. Medical Device Companies
9.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.4.5. CROs/CDMOs
9.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.5. Academic Research Institutions
9.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
9.6. Others (Regulatory Authorities, etc.)
9.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 10. Biosimulation Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2030
10.2. Regional Market Dashboard
10.3. Market Size & Forecasts Trend Analysis, 2018 - 2030:
10.4. North America
10.4.1. U.S.
10.4.1.1. Key country dynamics
10.4.1.2. Regulatory framework
10.4.1.3. Competitive scenario
10.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
10.4.2. Canada
10.4.2.1. Key country dynamics
10.4.2.2. Regulatory framework
10.4.2.3. Competitive scenario
10.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
10.4.3. Mexico
10.4.3.1. Key country dynamics
10.4.3.2. Regulatory framework
10.4.3.3. Competitive scenario
10.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
10.5. Europe
10.5.1. UK
10.5.1.1. Key country dynamics
10.5.1.2. Regulatory framework
10.5.1.3. Competitive scenario
10.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
10.5.2. Germany
10.5.2.1. Key country dynamics
10.5.2.2. Regulatory framework
10.5.2.3. Competitive scenario
10.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
10.5.3. France
10.5.3.1. Key country dynamics
10.5.3.2. Regulatory framework
10.5.3.3. Competitive scenario
10.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
10.5.4. Italy
10.5.4.1. Key country dynamics
10.5.4.2. Regulatory framework
10.5.4.3. Competitive scenario
10.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
10.5.5. Spain
10.5.5.1. Key country dynamics
10.5.5.2. Regulatory framework
10.5.5.3. Competitive scenario
10.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
10.5.6. Norway
10.5.6.1. Key country dynamics
10.5.6.2. Regulatory framework
10.5.6.3. Competitive scenario
10.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
10.5.7. Sweden
10.5.7.1. Key country dynamics
10.5.7.2. Regulatory framework
10.5.7.3. Competitive scenario
10.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
10.5.8. Denmark
10.5.8.1. Key country dynamics
10.5.8.2. Regulatory framework
10.5.8.3. Competitive scenario
10.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
10.6. Asia Pacific
10.6.1. Japan
10.6.1.1. Key country dynamics
10.6.1.2. Regulatory framework
10.6.1.3. Competitive scenario
10.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
10.6.2. China
10.6.2.1. Key country dynamics
10.6.2.2. Regulatory framework
10.6.2.3. Competitive scenario
10.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
10.6.3. India
10.6.3.1. Key country dynamics
10.6.3.2. Regulatory framework
10.6.3.3. Competitive scenario
10.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
10.6.4. Australia
10.6.4.1. Key country dynamics
10.6.4.2. Regulatory framework
10.6.4.3. Competitive scenario
10.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
10.6.5. South Korea
10.6.5.1. Key country dynamics
10.6.5.2. Regulatory framework
10.6.5.3. Competitive scenario
10.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
10.6.6. Thailand
10.6.6.1. Key country dynamics
10.6.6.2. Regulatory framework
10.6.6.3. Competitive scenario
10.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
10.7. Latin America
10.7.1. Brazil
10.7.1.1. Key country dynamics
10.7.1.2. Regulatory framework
10.7.1.3. Competitive scenario
10.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
10.7.2. Argentina
10.7.2.1. Key country dynamics
10.7.2.2. Regulatory framework
10.7.2.3. Competitive scenario
10.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
10.8. MEA
10.8.1. South Africa
10.8.1.1. Key country dynamics
10.8.1.2. Regulatory framework
10.8.1.3. Competitive scenario
10.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
10.8.2. Saudi Arabia
10.8.2.1. Key country dynamics
10.8.2.2. Regulatory framework
10.8.2.3. Competitive scenario
10.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
10.8.3. UAE
10.8.3.1. Key country dynamics
10.8.3.2. Regulatory framework
10.8.3.3. Competitive scenario
10.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
10.8.4. Kuwait
10.8.4.1. Key country dynamics
10.8.4.2. Regulatory framework
10.8.4.3. Competitive scenario
10.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company/Competition Categorization
11.2. Strategy Mapping
11.3. Company Market Position/Share Analysis, 2024
11.4. Company Profiles/Listing
11.4.1. Certara, USA
11.4.1.1. Company overview
11.4.1.2. Financial performance
11.4.1.3. Product benchmarking
11.4.1.4. Strategic initiatives
11.4.2. Dassault Systèmes
11.4.2.1. Company overview
11.4.2.2. Financial performance
11.4.2.3. Product benchmarking
11.4.2.4. Strategic initiatives
11.4.3. Advanced Chemistry Development
11.4.3.1. Company overview
11.4.3.2. Financial performance
11.4.3.3. Product benchmarking
11.4.3.4. Strategic initiatives
11.4.4. Simulation Plus
11.4.4.1. Company overview
11.4.4.2. Financial performance
11.4.4.3. Product benchmarking
11.4.4.4. Strategic initiatives
11.4.5. Schrodinger, Inc.
11.4.5.1. Company overview
11.4.5.2. Financial performance
11.4.5.3. Product benchmarking
11.4.5.4. Strategic initiatives
11.4.6. Chemical Computing Group ULC
11.4.6.1. Company overview
11.4.6.2. Financial performance
11.4.6.3. Product benchmarking
11.4.6.4. Strategic initiatives
11.4.7. Physiomics Plc
11.4.7.1. Company overview
11.4.7.2. Financial performance
11.4.7.3. Product benchmarking
11.4.7.4. Strategic initiatives
11.4.8. Rosa & Co. LLC
11.4.8.1. Company overview
11.4.8.2. Financial performance
11.4.8.3. Product benchmarking
11.4.8.4. Strategic initiatives
11.4.9. BioSimulation Consulting Inc.
11.4.9.1. Company overview
11.4.9.2. Financial performance
11.4.9.3. Product benchmarking
11.4.9.4. Strategic initiatives
11.4.10. Genedata AG
11.4.10.1. Company overview
11.4.10.2. Financial performance
11.4.10.3. Product benchmarking
11.4.10.4. Strategic initiatives
11.4.11. Instem Group of Companies
11.4.11.1. Company overview
11.4.11.2. Financial performance
11.4.11.3. Product benchmarking
11.4.11.4. Strategic initiatives
11.4.12. PPD, Inc.
11.4.12.1. Company overview
11.4.12.2. Financial performance
11.4.12.3. Product benchmarking
11.4.12.4. Strategic initiatives
11.4.13. Yokogawa Insilico Biotechnology GmbH
11.4.13.1. Company overview
11.4.13.2. Financial performance
11.4.13.3. Product benchmarking
11.4.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings